Pyrojas Inc.
- | Biotech or pharma, therapeutic R&D
PyrOjas Corporation
PyrOjas Corporation is a biotechnology company advancing innovative solutions in cancer immunotherapy. The company’s proprietary platforms, PyroTIMER™ and PyroCells™, address key challenges in T cell therapies and personalized cancer vaccines.
- PyroTIMER™: A universal, licensable technology designed to enhance the persistence, activation, and efficacy of CAR-T and TCR-T cell therapies by overcoming immunosuppressive tumor microenvironments.
- PyroCells™: A personalized cancer vaccine platform leveraging whole-tumor modifications to address tumor heterogeneity, enabling scalable, point-of-care manufacturing within 24 hours.
PyrOjas aims to improve treatment outcomes and expand access to effective cancer therapies through robust science, strong industry partnerships, and a focus on patient-centric innovation.
Address
New YorkNew York
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}